2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
124
Multiple Myeloma
84
Precursor Cell Lymphoblastic Leukemia-Lymphoma
76
Lymphoma
73
Lymphoma, Non-Hodgkin
66
Leukemia
66
Myelodysplastic Syndromes
56
Hodgkin Disease
53
Lymphoma, Large B-Cell, Diffuse
37
Lymphoma, Mantle-Cell
33
Breast Neoplasms
32
Neuroblastoma
30
Leukemia, Lymphocytic, Chronic, B-Cell
30
Burkitt Lymphoma
30
Lymphoma, Follicular
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
26
Recurrence
24
Sarcoma
18
Neoplasms, Plasma Cell
18
Hematologic Neoplasms
18
Central Nervous System Neoplasms
18
Lymphoma, B-Cell, Marginal Zone
17
Leukemia, Biphenotypic, Acute
16
Myeloproliferative Disorders
15
Lymphoma, Large-Cell, Immunoblastic
15
Congenital Abnormalities
15
Brain Neoplasms
14
Leukemia, Myelomonocytic, Chronic
13
Anemia, Refractory, with Excess of Blasts
13
Medulloblastoma
12
Interventions
Cyclophosphamide
4
Topotecan
3
Ifosfamide
3
Doxorubicin
3
seclidemstat
2
pazopanib
2
Biopsy
2
tebentafusp
1
selinexor
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
fludarabine phosphate
1
fludarabine
1
dostarlimab
1
devimistat
1
cobimetinib
1
cabozantinib
1
atezolizumab
1
Zoledronic Acid
1
X-Rays
1
Vemurafenib
1
Sunitinib
1
Specimen Handling
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Radiation
1
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Clear Cell
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled